Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Hold" from Brokerages

Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has received a consensus rating of "Hold" from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $12.9545.

ARDT has been the subject of several research reports. The Goldman Sachs Group restated a "neutral" rating and issued a $13.00 price objective on shares of Ardent Health in a research report on Thursday. Truist Financial increased their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a research note on Thursday. Weiss Ratings reissued a "sell (d+)" rating on shares of Ardent Health in a report on Friday, June 12th. UBS Group upped their price objective on Ardent Health from $13.00 to $13.50 and gave the stock a "buy" rating in a report on Thursday, May 7th. Finally, Guggenheim increased their price objective on Ardent Health from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Thursday.

Insider Buying and Selling at Ardent Health

In other news, CFO Alfred Lumsdaine purchased 10,000 shares of the business's stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the purchase, the chief financial officer directly owned 329,183 shares of the company's stock, valued at $2,900,102.23. The trade was a 3.13% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is currently owned by insiders.

Institutional Trading of Ardent Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company lifted its stake in Ardent Health by 3.7% in the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company's stock valued at $255,000 after buying an additional 1,072 shares during the period. Geode Capital Management LLC grew its position in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after buying an additional 1,769 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company's stock worth $25,000 after buying an additional 2,638 shares during the period. Alliancebernstein L.P. increased its stake in shares of Ardent Health by 24.8% in the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company's stock valued at $218,000 after acquiring an additional 3,272 shares during the last quarter. Finally, New York State Common Retirement Fund increased its stake in shares of Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company's stock valued at $85,000 after acquiring an additional 3,400 shares during the last quarter.

Ardent Health Trading Up 3.9%

ARDT stock opened at $11.60 on Friday. The business has a fifty day moving average price of $9.93 and a 200 day moving average price of $9.48. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48. The stock has a market capitalization of $1.66 billion, a price-to-earnings ratio of 21.09, a P/E/G ratio of 2.62 and a beta of 0.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.06). Ardent Health had a return on equity of 10.45% and a net margin of 1.22%.The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Analysts expect that Ardent Health will post 1.06 EPS for the current fiscal year.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source